Go Pro
→ My top 3 AI picks for the next decade (From The Oxford Club) (Ad)tc pixel Free JANX Stock Alerts

Janux Therapeutics (JANX) Short Interest Ratio & Short Volume

Janux Therapeutics logo
$18.03 -0.75 (-3.99%)
As of 08/28/2026 04:00 PM Eastern
Compare

Janux Therapeutics Short Interest Overview

As of August 14, 2026, Janux Therapeutics (JANX) had a short interest of 6.63 million shares sold short, representing 11.77% of the public float. This marks a 11.88% increase in short interest since the prior report. The short interest ratio (days to cover) is 10.9, meaning it would take 10.9 days of the average trading volume of 698,921 shares to cover all short positions.

Current Short Interest
6,626,696 shares
Previous Short Interest
5,922,899 shares
Change Vs. Previous Month
11.88%
Dollar Volume Sold Short
$106.82 million
Short Interest Ratio
10.9 Days to Cover
Last Record Date
August 14, 2026
Outstanding Shares
61,140,000 shares
Short Percent of Float
11.77%
Today's Trading Volume
637,808 shares
Average Trading Volume
698,921 shares
Today's Volume Vs. Average
91%
Short Selling Janux Therapeutics?
A Guide To High-Short-Interest Stocks

Sign up to receive the latest short interest report for Janux Therapeutics and its competitors with MarketBeat's FREE newsletter.

Get Report
SMS is currently available in Australia, Belgium, Canada, France, Germany, Ireland, Italy, New Zealand, the Netherlands, Singapore, South Africa, Spain, Switzerland, the United Kingdom, and the United States. By entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy.
Skip Charts & View Short Interest History
Short Interest ChartDays to Cover ChartShort Percent of Float Chart

JANX Short Interest Over Time

JANX Days to Cover Over Time

JANX Percentage of Float Shorted Over Time

Janux Therapeutics Tesla Short Interest History & Recent Changes

Export
Report DateTotal Shares Sold ShortDollar Volume Sold ShortChange from Previous ReportPercentage of Float ShortedDays to CoverPrice on Report Date
8/14/20266,626,696 shares $106.82 million +11.9%11.8%10.9 $16.12
7/31/20265,922,899 shares $89.85 million -8.2%10.5%7.74 $15.17
7/15/20266,454,019 shares $103.46 million -9.2%11.5%6.43 $16.03
6/30/20267,108,085 shares $109.18 million -6.7%12.7%3.59 $15.36
6/15/20267,615,380 shares $104.64 million -5.9%13.6%10.96 $13.74
5/29/20268,091,847 shares $118.06 million +3.4%14.4%6.83 $14.59
5/15/20267,827,096 shares $108.72 million -1.3%13.9%9.66 $13.89
4/30/20267,932,981 shares $114.00 million +6.6%14.1%7.4 $14.37
4/15/20267,440,069 shares $111.90 million -3.9%13.2%8.27 $15.04
3/31/20267,744,629 shares $107.65 million -22.7%13.8%5.51 $13.90
3/13/202610,020,131 shares $136.07 million +0.2%23.3%12.01 $13.58
2/27/20269,996,191 shares $136.05 million -1.5%23.3%12.52 $13.61
2/13/202610,144,569 shares $133.30 million -3.2%18.1%7.38 $13.14
1/30/202610,476,584 shares $143.63 million +10.9%24.7%5.58 $13.71
1/15/20269,444,405 shares $129.58 million +2.2%22.2%6.36 $13.72
12/31/20259,239,650 shares $127.51 million +24.9%21.8%3.5 $13.80
12/15/20257,395,136 shares $111.81 million -2.8%17.4%1.98 $15.12
11/28/20257,606,181 shares $260.85 million +6.7%17.9%6.91 $34.30
11/14/20257,131,951 shares $208.82 million +2.7%16.8%6.84 $29.28
10/31/20256,946,508 shares $199.43 million -18.9%16.4%5.8 $28.71
10/15/20258,560,000 shares $242.08 million -4.1%15.8%10.2 $28.28
9/30/20258,930,000 shares $218.25 million +7.6%16.4%11 $24.44
9/15/20258,300,000 shares $195.55 million +3.1%15.4%10.6 $23.56
8/31/20258,050,000 shares $182.90 million -0.4%14.9%10.5 $22.72
8/15/20258,080,000 shares $202.89 million -7.5%15.0%9.7 $25.11
7/31/20258,730,000 shares $209.61 million -9.5%16.0%9.9 $24.01
7/15/20259,650,000 shares $248.58 million -6.0%19.5%10.7 $25.76
6/30/202510,260,000 shares $237.01 million -3.3%20.7%10.7 $23.10
6/15/202510,610,000 shares $264.19 million -0.6%21.4%11.2 $24.90
5/31/202510,670,000 shares $252.99 million -7.6%21.6%10.9 $23.71
5/15/202511,550,000 shares $268.77 million +19.7%23.3%11.4 $23.27
4/30/20259,650,000 shares $320.38 million +3.3%19.5%10.2 $33.20
4/15/20259,340,000 shares $271.42 million -7.5%18.9%10.2 $29.06
3/31/202510,100,000 shares $272.70 million -3.8%20.4%10.1 $27.00
3/15/202510,500,000 shares $322.14 million +12.1%21.2%11.2 $30.68
2/28/20259,370,000 shares $308.18 million +3.1%19.1%8.7 $32.89
2/15/20259,090,000 shares $330.60 million +11.8%18.9%7.6 $36.37
1/31/20258,130,000 shares $353.49 million -4.9%17.0%7 $43.48
1/15/20258,550,000 shares $375.60 million +11.3%17.9%7.6 $43.93
12/31/20247,680,000 shares $411.19 million +19.8%16.4%7.3 $53.54
Buy this stock today (Ad)

Marc Chaikin, founder of Chaikin Analytics, is sharing a strategy he calls 'Sell This, Buy That' - a way to move out of overpriced AI stocks before the tech trade breaks down and into lesser-known names with real potential to challenge the Mag 7. One pick he calls 'an upgrade to Tesla stock' is a little-known company that just inked a partnership with Nvidia, positioning it ahead of Tesla in the autonomous vehicle race.tc pixel

Get the name, ticker, and full Hotlist before markets open
12/15/20246,410,000 shares $391.72 million +43.1%13.6%6.8 $61.11
11/30/20244,480,000 shares $202.54 million +6.9%9.5%4.8 $45.21
11/15/20244,190,000 shares $204.30 million -2.8%9.8%6.6 $48.76
10/31/20244,310,000 shares $232.70 million -0.5%10.2%7.2 $53.99
10/15/20244,330,000 shares $228.36 million +25.1%10.7%7.5 $52.74
9/30/20243,460,000 shares $157.19 million +4.5%8.9%6.2 $45.43
9/15/20243,310,000 shares $165.53 million -0.3%8.6%5.6 $50.01
8/31/20243,320,000 shares $155.97 million +2.2%8.8%5.8 $46.98
8/15/20243,250,000 shares $134.94 million -11.2%8.6%4.8 $41.52
7/31/20243,660,000 shares $148.60 million -0.5%10.3%4.8 $40.60
7/15/20243,680,000 shares $159.97 million +3.1%10.4%4.6 $43.47
6/30/20243,570,000 shares $149.55 million +24.4%10.1%4 $41.89
6/15/20242,870,000 shares $120.54 million -4.0%8.1%3.4 $42.00
5/31/20242,990,000 shares $159.97 million +3.8%8.5%3.7 $53.50
5/15/20242,880,000 shares $136.74 million -12.7%8.5%2.5 $47.48
4/30/20243,300,000 shares $188.10 million -4.1%9.6%3.2 $57.00
4/15/20243,440,000 shares $178.40 million -8.3%10.0%3.8 $51.86
3/31/20243,750,000 shares $141.19 million +20.6%11.6%5.3 $37.65
3/15/20243,110,000 shares $122.69 million +7.2%9.6%4.6 $39.45
2/29/20242,900,000 shares $140.30 million +18.9%9.2%4.8 $48.38
2/15/20242,440,000 shares $23.18 million -0.4%8.6%6.6 $9.50
1/31/20242,450,000 shares $20.97 million -1.6%8.6%21.5 $8.56
1/15/20242,490,000 shares $25.27 million -0.8%8.8%20.6 $10.15
12/31/20232,510,000 shares $26.93 million +3.7%8.8%20.3 $10.73
12/15/20232,420,000 shares $25.10 million -5.1%8.5%20.5 $10.37
11/30/20232,550,000 shares $22.26 million +2.4%8.9%23.7 $8.73
11/15/20232,490,000 shares $21.86 million -4.6%8.7%23.5 $8.78
10/31/20232,610,000 shares $16.76 million -3.7%8.7%30.4 $6.42
10/15/20232,710,000 shares $23.69 million -5.9%9.1%31.8 $8.74
9/30/20232,880,000 shares $29.03 million -4.0%9.6%34.5 $10.08
9/15/20233,000,000 shares $29.61 million +1.4%10.0%31.7 $9.87
8/31/20232,960,000 shares $32.56 million +1.7%9.9%29.6 $11.00
8/15/20232,910,000 shares $34.92 million -3.0%9.7%26.4 $12.00
7/31/20233,000,000 shares $42 million +0.3%11.0%20 $14.00
7/15/20232,990,000 shares $37.26 million No Change11.8%20.8 $12.46
6/30/20232,990,000 shares $35.49 million -1.0%13.0%22.9 $11.87
6/15/20233,020,000 shares $39.56 million +4.9%13.1%24 $13.10
5/31/20232,880,000 shares $33.47 million -2.4%12.5%23.6 $11.62
5/15/20232,950,000 shares $35.49 million +0.3%12.8%26.6 $12.03
4/30/20232,940,000 shares $45.04 million +7.3%13.0%42.3 $15.32
4/15/20232,740,000 shares $40.11 million +4.6%12.1%35.7 $14.64
3/31/20232,620,000 shares $31.70 million -1.1%11.8%23.3 $12.10
3/15/20232,650,000 shares $35.64 million +3.9%11.9%22.6 $13.45
2/28/20232,550,000 shares $42.41 million +0.4%11.5%21.5 $16.63
2/15/20232,540,000 shares $43.21 million +8.6%11.4%21.7 $17.01
1/31/20232,340,000 shares $51.97 million +8.8%10.5%19.5 $22.21
1/15/20232,150,000 shares $44.23 million -13.7%9.7%17.5 $20.57
12/30/20222,490,000 shares $32.79 million +4.2%11.3%24.3 $13.17
12/15/20222,390,000 shares $30.35 million -9.5%10.8%30.7 $12.70
11/30/20222,640,000 shares $36.01 million -2.2%12.0%36.8 $13.64
Trump Takes Emergency Action - Plus Elon Musk's New Venture (Ad)

Elon Musk has quietly launched a new venture - one that has nothing to do with rockets, EVs, or Neuralink. Trump has issued emergency support to accelerate the rollout, and it's already live in multiple states. The Financial Times reports Sam Altman is personally calling people to build this for OpenAI. A few little-known companies control the entire supply chain - meaning anyone who wants access must go through them. Their stocks are available to buy right now.tc pixel

See which companies control the supply chain behind this emerging tech
11/15/20222,700,000 shares $44.50 million -21.3%12.2%40.1 $16.48
10/31/20223,430,000 shares $62.01 million No Change15.6%58.7 $18.08
10/15/20223,430,000 shares $44.73 million -0.6%15.6%73.4 $13.04
9/30/20223,450,000 shares $46.71 million +1.8%15.7%63.5 $13.54
9/15/20223,390,000 shares $44.92 million +1.2%15.4%45.1 $13.25
8/31/20223,350,000 shares $36.25 million +3.1%15.2%45 $10.82
8/15/20223,250,000 shares $46.83 million -3.6%14.8%43.2 $14.41
7/31/20223,370,000 shares $41.86 million +0.9%15.4%39.1 $12.42
7/15/20223,340,000 shares $56.25 million +6.4%15.2%36.3 $16.84
6/30/20223,140,000 shares $38.34 million +3.3%14.3%34.8 $12.21
6/15/20223,040,000 shares $35.26 million +1.7%13.9%39.8 $11.60
5/31/20222,990,000 shares $33.28 million No Change13.7%39.2 $11.13
5/15/20222,990,000 shares $33.07 million +6.0%13.7%36.2 $11.06
4/30/20222,820,000 shares $27.75 million -5.1%12.9%36.4 $9.84
4/15/20222,970,000 shares $40.01 million -1.0%13.6%40 $13.47
3/31/20223,000,000 shares $43.02 million +3.1%13.7%38.1 $14.34
3/15/20222,910,000 shares $49.38 million +3.9%13.3%31.3 $16.97
2/28/20222,800,000 shares $48.38 million +2.9%12.8%26.5 $17.28
2/15/20222,720,000 shares $48.55 million -1.8%12.4%24.6 $17.85
1/31/20222,770,000 shares $42.19 million +3.8%12.4%25.2 $15.23
1/15/20222,670,000 shares $42.08 million +3.9%11.9%24.6 $15.76
12/31/20212,570,000 shares $50.71 million +6.6%11.5%25 $19.73
12/15/20212,410,000 shares $47.43 million +11.6%10.8%23.1 $19.68
11/30/20212,160,000 shares $38.40 million +9.6%10.2%17 $17.78
11/15/20211,970,000 shares $41.76 million +3.7%9.3%14.4 $21.20
10/29/20211,900,000 shares $46.27 million -2.6%9.0%12.6 $24.35
10/15/20211,950,000 shares $41.20 million +7.7%9.3%11.6 $21.13
9/30/20211,810,000 shares $39.15 million +37.1%8.6%8.3 $21.63
9/15/20211,320,000 shares $41.04 million +20.0%6.3%5.5 $31.09
8/31/20211,100,000 shares $37.51 million +26.2%5.2%4.2 $34.10

JANX Short Interest - Frequently Asked Questions

Short interest is the volume of Janux Therapeutics shares that have been sold short but have not yet been covered or closed out. As of August 14th, investors have sold 6,626,696 shares of JANX short. 11.77% of Janux Therapeutics' shares are currently sold short. Learn More on Janux Therapeutics' current short interest.

The short interest ratio, also known as the "days to cover ratio", is calculated by dividing the number of shares of a stock sold short divided by its average trading volume. A short interest ratio ranging between 1 and 4 generally indicates strong positive sentiment about a stock and a lack of short sellers. A short interest ratio of 10 or greater indicates strong pessimism about a stock. JANX shares currently have a short interest ratio of 10.9. Learn More on Janux Therapeutics's short interest ratio.

Companies that have a short interest as a percentage of float below 10% indicates positive investor sentiment and few short sellers. Stocks with a short interest percentage above 10% is considered high, suggesting some investors are pessimistic about the stock. Companies with a short interest percentage of 20% or more indicates widespread negative sentiment. 11.77% of Janux Therapeutics' floating shares are currently sold short.

Janux Therapeutics saw a increase in short interest in August. As of August 14th, there was short interest totaling 6,626,696 shares, an increase of 11.9% from the previous total of 5,922,899 shares. Changes in short volume can be used to identify positive and negative investor sentiment. Investors that short sell a stock are betting that its price will decline in the future. An increase in short sale volume suggests bearish (negative) sentiment among investors. A decrease on short sale volume suggests bullish (positive) sentiment.

11.77% of Janux Therapeutics' shares are currently sold short. Here is how the short interest of companies in the industry of "biotechnology" compare to Janux Therapeutics: Denali Therapeutics Inc. (12.44%), Viking Therapeutics, Inc. (20.17%), Legend Biotech Corporation Sponsored ADR (9.60%), Arcus Biosciences, Inc. (11.77%), AbCellera Biologics Inc. (18.83%), uniQure N.V. (16.28%), Veracyte, Inc. (8.58%), Celldex Therapeutics, Inc. (10.17%), Alumis Inc. (6.82%), NewAmsterdam Pharma Company N.V. (12.13%),

As of the most recent reporting period, the following stocks had the largest short interest positions: SPDR S&P 500 ETF Trust ($71.57 billion), Invesco QQQ ($46.97 billion), iShares Russell 2000 ETF ($24.02 billion), Nebius Group N.V. ($15.37 billion), Sandisk Corporation ($12.60 billion), SPDR S&P Biotech ETF ($12.14 billion), Western Digital Corporation ($10.32 billion), iShares 20+ Year Treasury Bond ETF ($8.38 billion), VanEck Semiconductor ETF ($7.62 billion), and iShares iBoxx $ High Yield Corporate Bond ETF ($7.07 billion). View all of the most shorted stocks.

Short selling JANX is an investing strategy that aims to generate trading profit from Janux Therapeutics as its price is falling. JANX shares are trading down $0.75 today. To short a stock, an investor borrows shares, sells them and buys the shares back on the public market later to return it to the lender. Short sellers are betting that a stock will decline in price. If the stock does drop after selling, the short seller buys it back at a lower price and returns it to the lender. The difference between the sell price and the buy price is the trader's profit.

A short squeeze for Janux Therapeutics occurs when it has a large amount of short interest and its stock appreciates in price. This forces short sellers to cover their short interest positions by buying actual shares of JANX, which in turn drives the price of the stock up even further.

Short interest is typically published by a stock exchange once per month. However, NASDAQ publishes a report for U.S. stocks, including JANX, twice per month. The most recent reporting period available is August, 14 2026.

Understanding short interest metrics can help you assess how traders are positioning around a stock like JANX:

  • Shares Sold Short: The total number of shares that have been sold by short sellers but have not yet been covered or closed out. A high number may indicate bearish sentiment.
  • Short Float: The percentage of a company’s publicly available shares (or "float") that are sold short. A higher short float suggests a greater portion of the stock is being bet against.
  • Days to Cover (Short Interest Ratio): This estimates how many days it would take short sellers to cover their positions, based on average daily trading volume. Higher values can signal potential for a short squeeze if buying pressure increases.

These metrics are often used by traders to gauge sentiment, volatility risk, and the potential for price movements based on short covering activity.


Related Companies
Short Interest Tools

Short interest data for NASDAQ:JANX is sourced from the Financial Industry Regulatory Authority (FINRA), with the most recent report published on 8/25/2026. FINRA publishes updated short interest twice a month.
From Our Partners
ALERT: Drop these 5 stocks before the market opens tomorrow!
The Wall Street Journal is already raising the alarm about a potential market crash, and Weiss Ratings researc...
Weiss Ratings | Sponsoredtc pixel
Louis Navellier: My #1 AI stock for 2026 (name & ticker inside)
Louis Navellier's Stock Grader system helped him flag Nvidia before its 82,000% run and has identified the top...
InvestorPlace | Sponsoredtc pixel
Ready to give options a try? Your first trade (Ticker included) -INSIDE
Tired of trying tactic after tactic when it comes to options trades... only to be met with market noise and st...
Base Camp Trading | Sponsoredtc pixel
Trump Takes Emergency Action - Plus Elon Musk's New Venture
Elon Musk has quietly launched a new venture - one that has nothing to do with rockets, EVs, or Neuralink. Tru...
Altimetry | Sponsoredtc pixel
Iran War Shock: What I Was Told In That Private Meeting
You’re Being LIED To About The Iran War Forget EVERYTHING you’ve heard about the Iran war. Especially th...
Banyan Hill Publishing | Sponsoredtc pixel
Buy this stock today
Marc Chaikin, founder of Chaikin Analytics, is sharing a strategy he calls 'Sell This, Buy That' - a way to mo...
Chaikin Analytics | Sponsoredtc pixel
My top 3 AI picks for the next decade
Alexander Green bought Apple in 1996, recommended Nvidia at a split-adjusted 66 cents in 2004, and picked up A...
The Oxford Club | Sponsoredtc pixel
Here’s the stock symbol I’ve promised
Whitney Tilson of Stansberry Research has long recommended Berkshire Hathaway as a core retirement holding - b...
Stansberry Research | Sponsoredtc pixel